---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-171917"
form_type: "8-K"
ticker: "ACAD"
cik: "0001070494"
company_name: "ACADIA PHARMACEUTICALS INC"
filed_at: "2022-06-10T23:59:59+00:00"
generated_at: "2026-06-25T02:36:53.940741+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Acadia stockholders approve 6M share increase for equity plan, elect directors

## Summary
- Stockholders approved amendment to 2010 Equity Incentive Plan, increasing authorized shares by 6,000,000 (135.2M for, 6.6M against).
- Class III directors Laura A. Brege, Stephen R. Davis, and Elizabeth A. Garofalo elected with 89.4M, 127.1M, and 117.4M votes for, respectively.
- Advisory vote on executive compensation approved (127.2M for, 3.4M against).
- Ratification of Ernst & Young as independent auditor for FY2022 passed (141.5M for).

## SEC filing metadata
- accession: 0001193125-22-171917
- form_type: 8-K
- ticker: ACAD
- cik: 0001070494
- company_name: ACADIA PHARMACEUTICALS INC
- filed_at: 2022-06-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1070494/000119312522171917/0001193125-22-171917-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1070494/000119312522171917/d364504d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-171917
- JSON: https://secwatch.observer/filing/0001193125-22-171917.json
- Plain text: https://secwatch.observer/filing/0001193125-22-171917.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.